JOURNAL OF DIABETES AND ITS

COMPLICATIONS

AUTHOR INFORMATION PACK

TABLE OF CONTENTS XXX

. .

Description p.1
Audience p.1
Impact Factor p.1
Abstracting and Indexing p.2
Editorial Board p.2
Guide for Authors p.4
ISSN: 1056-8727

DESCRIPTION
.

Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and
researchers, that publishes original research about the pathogenesis, diagnosis and management of
diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular
aspects of glucose homeostasis.

The primary purpose of JDC is to act as a source of information usable by diabetes practitioners
and researchers to increase their knowledge about mechanisms of diabetes and complications
development, and promote better management of people with diabetes who are at risk for those
complications.

Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as
well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated
diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and
insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose
homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic
retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease;
gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts
on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further
information or help, please visit our support pages: http://service.elsevier.com

AUDIENCE
.

Those who treat patients with diabetes and its disorders, including Endocrinologists, Urologists, and
Nephrologists.

IMPACT FACTOR
.

2015: 2.955 Thomson Reuters Journal Citation Reports 2016

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 1

ABSTRACTING AND INDEXING
.

BIOSIS
Elsevier BIOBASE
Current Contents/Clinical Medicine
MEDLINE
EMBASE
National Diabetes Information Clearinghouse (NDIC)
Reference Update
Research Alert
Scisearch
Scopus

EDITORIAL BOARD
.

Editor-in-Chief
Vivian Fonseca, MD, Professor of Medicine and Pharmacology, Tullis Tulane Alumni Chair in Diabetes, Chief -
Section of Endocrinology, Tulane University Health Sciences Center, 1430 Tulane Avenue - SL 53, New Orleans,
LA 70112, USA
Associate Editors
Stefano Del Prato, MD, Universit di Pisa, Pisa, Italy
Cyrus V. DeSouza, MBBS, University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA
Franck Mauvais-Jarvis, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
Rodica Pop-Busui, MD, PhD, University of Michigan Health System, Ann Arbor, Michigan, USA
Stephen M. Twigg, The University of Sydney, Sydney, New South Wales, Australia
Editorial Board
S. Andrikopoulos, Heidelberg, Victoria, Australia
S. Arslanian, Pittsburgh, Pennsylvania, USA
A. Avogaro, Padova, Italy
G. L. Bakris, Chicago, Illinois, USA
E. J. Belin de Chantemele, Augusta, Georgia, USA
E. Boyko, Seattle, Washington, USA
R. Burcelin, Toulouse Cedex, France
B. Charbonnel, Nantes, France
A. Consoli, Chieti, Italy
J. Crandall, New York, New York, USA
H. Dong, Pittsburgh, Pennsylvania, USA
D. Ehrmann, Chicago, Illinois, USA
C. Evans-Molina, Indianapolis, Indiana, USA
F. Folli, San Antonio, Texas, USA
B. Gallwitz, Tbingen, Germany
A. Garcia-Ocana, New York, New York, USA
H-U Haering, Tbingen, Germany
M. Hussain, Baltimore, Maryland, USA
L. Ji, Beijing, China
I. Jialal, Sacramento, California, USA
J. C. Jonas, Brussels, Belgium
J. K. Kim, Worcester, Massachusetts, USA
J. Leahy, Colchester, Vermont, USA
M. R. Loeken, Boston, Massachusetts, USA
R. Malik, Manchester, England, UK
J. Meigs, Boston, Massachusetts, USA
V. Mohan, Seattle, Washington, USA
U. Ozcan, Boston, Massachusetts, USA
R. Pratley, Orlando, Florida, USA
R. Retnakaran, Toronto, Ontario, Canada
K. Reynolds, Pasadena, California, USA
S. Rich, Charlottesville, Virginia, USA
G. Schernthaner, Vienna, Austria
Y. Seino, Osaka, Japan
W H-H Sheu, Taichung, Taiwan
A. Solini, Pisa, Italy

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 2

C. Stehouwer, Maastricht, Netherlands
F. Urano, St. Louis, Missouri, USA
A. Vaag, Copenhagen, Denmark
L. Van Gaal, Antwerp, Belgium
S. Volpato, Ferrara, Italy
A. Zsombok, New Orleans, Louisiana, USA

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 3

GUIDE FOR AUTHORS
.

Aims and Scope

The primary purpose of Journal of Diabetes and Its Complications is to act as a source of information,
usable by those caring for patients with diabetes mellitus who are thereby at risk for development
of those complications which all too often appear with time. While our primary aim is to assist the
practitioner in his/her care of such patients, and to afford access to information that may allow the
prevention of such complications, it is the Editors' wish to function as a forum for that information
which, while still experimental, may shed light upon current thinking of those active in the fields
appropriate to the aims of Journal of Diabetes and its Complications.

In addition to general articles on clinical aspects of diabetes mellitus, Journal of Diabetes and
its Complications also presents articles on basic research in all areas of diabetes and its related
syndromes. Topics covered relevant to the diabetic patient will include diagnosis, pathogenesis, and
clinical management of the following: diabetic retinopathy, neuropathy and nephropathy; peripheral
vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence;
and hypertension and hyperlipidemia. Journal of Diabetes and its Complications will also publish
papers on the general pathogenesis and prevention of diabetes.

Criteria for initial considerations for papers submitted will be originality, statistical probability of all
data, and applicability to the aims of the Journal as a whole. Additional weight will be afforded to
those submissions that are concise and comprehensible. All potentially acceptable manuscripts will be
subjected to the process of peer review. To aid with the peer-review process, at least five suggested
reviewers whose expertise falls within the scope of the submitted manuscript must be provided. For
each suggested reviewer include full names, addresses (physical and email), phone and fax numbers.
Journal Principles
All manuscripts submitted to Journal of Diabetes and Its Complications should report original research
not previously published or being considered for publication elsewhere, make explicit any conflict of
interest, identify sources of funding and generally be of a high ethical standard.

Submission of a manuscript to this journal gives the publisher the right to publish that paper if it
is accepted. Manuscripts may be edited to improve clarity and expression. Submission of a paper
to Journal of Diabetes and its Complications is understood to imply that it has not previously been
published and that it is not being considered for publication elsewhere.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for
review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:
E-mail address
Full postal address

All necessary files have been uploaded:

Manuscript:
Include keywords
All figures (include relevant captions)
All tables (including titles, description, footnotes)
Ensure all figure and table citations in the text match the files provided
Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)

Further considerations
Manuscript has been 'spell checked' and 'grammar checked'
All references mentioned in the Reference List are cited in the text, and vice versa
Permission has been obtained for use of copyrighted material from other sources (including the
Internet)

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 4

 Relevant declarations of interest have been made
Journal policies detailed in this guide have been reviewed
Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Ethics
Work on human beings that is submitted to the journal should comply with the principles laid
down in the Declaration of Helsinki "Recommendations guiding physicians in biomedical research
involving human subjects", adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964
(and its successive amendments). The manuscript should contain a statement that the work has
been approved by the appropriate ethical committees related to the institution(s) in which it was
performed. Studies involving experiments with animals must state that their care was in accordance
with institution guidelines.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations
that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/
registrations, and grants or other funding. If there are no conflicts of interest then please state this:
'Conflicts of interest: none'. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis or as an electronic
preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more
information), that it is not under consideration for publication elsewhere, that its publication is
approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or
in any other language, including electronically without the written consent of the copyright-holder. To
verify originality, your article may be checked by the originality detection service CrossCheck.
Author consent
The Corresponding Author must submit an Author Consent document with their manuscript. All
authors must sign the Author Consent document, indicating the manuscript is approved by all named
authors and the order of authors listed in the manuscript has been approved by all authors.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their
manuscript and provide the definitive list of authors at the time of the original submission. Any
addition, deletion or rearrangement of author names in the authorship list should be made only
before the manuscript has been accepted and only if approved by the journal Editor. To request such
a change, the Editor must receive the following from the corresponding author: (a) the reason
for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of
authors after the manuscript has been accepted. While the Editor considers the request, publication
of the manuscript will be suspended. If the manuscript has already been published in an online issue,
any requests approved by the Editor will result in a corrigendum.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal
in accordance with International Committee of Medical Journal Editors recommendations. Trials
must register at or before the onset of patient enrolment. The clinical trial registration number
should be included at the end of the abstract of the article. A clinical trial is defined as any
research study that prospectively assigns human participants or groups of humans to one or more
health-related interventions to evaluate the effects of health outcomes. Health-related interventions
include any intervention used to modify a biomedical or health-related outcome (for example drugs,

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 5

surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care
changes). Health outcomes include any biomedical or health-related measures obtained in patients or
participants, including pharmacokinetic measures and adverse events. Purely observational studies
(those in which the assignment of the medical intervention is not at the discretion of the investigator)
will not require registration.
Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is
more suitable in one of our other participating journals, then you may be asked to consider transferring
the article to one of those. If you agree, your article will be transferred automatically on your behalf
with no need to reformat. Please note that your article will be reviewed again by the new journal.
More information.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see
more information on this). An e-mail will be sent to the corresponding author confirming receipt of
the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version
of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations. If
excerpts from other copyrighted works are included, the author(s) must obtain written permission
from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for
use by authors in these cases.

For open access articles: Upon acceptance of an article, authors will be asked to complete an
'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles
is determined by the author's choice of user license.

Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More
information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or
preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in
the collection, analysis and interpretation of data; in the writing of the report; and in the decision to
submit the article for publication. If the funding source(s) had no such involvement then this should
be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply
with their funder's open access policies. Some funding bodies will reimburse the author for the Open
Access Publication Fee. Details of existing agreements are available online.
After acceptance, open access papers will be published under a noncommercial license. For authors
requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.
Open access
This journal offers authors a choice in publishing their research:

Open access
Articles are freely available to both subscribers and the wider public with permitted reuse.
An open access publication fee is payable by authors or on their behalf, e.g. by their research funder
or institution.
Subscription
Articles are made available to subscribers as well as developing countries and patient groups through
our universal access programs.
No open access publication fee payable by authors.

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 6

Regardless of how you choose to publish your article, the journal will apply the same peer review
criteria and acceptance standards.

For open access articles, permitted third party (re)use is defined by the following Creative Commons
user licenses:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective
work (such as an anthology), as long as they credit the author(s) and provided they do not alter or
modify the article.
The open access publication fee for this journal is USD 3000, excluding taxes. Learn more about
Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of
green open access options available. We recommend authors see our green open access page for
further information. Authors can also self-archive their manuscripts immediately and enable public
access from their institution's repository after an embargo period. This is the version that has been
accepted for publication and which typically includes author-incorporated changes suggested during
submission, peer review and in editor-author communications. Embargo period: For subscription
articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers
before an article becomes freely available to the public. This is the embargo period and it begins from
the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 12 months.
Elsevier Publishing Campus
The Elsevier Publishing Campus (www.publishingcampus.com) is an online platform offering free
lectures, interactive training and professional advice to support you in publishing your research. The
College of Skills training offers modules on how to prepare, write and structure your article and
explains how editors will look at your paper when it is submitted for publication. Use these resources,
and more, to ensure that your submission will be the best that you can make it.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of
these). Authors who feel their English language manuscript may require editing to eliminate possible
grammatical or spelling errors and to conform to correct scientific English may wish to use the English
Language Editing service available from Elsevier's WebShop.
Language service
The Language of the journal is English. Upon request, Elsevier will direct authors to an agent who can
check and improve the English of their paper (before submission). Please visit our Support Center
for further information.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which
should be documented in the paper. Appropriate consents, permissions and releases must be obtained
where an author wishes to include case details or other personal information or images of patients
and any other individuals in an Elsevier publication. Written consents must be retained by the author
and copies of the consents or evidence that such consents have been obtained must be provided to
Elsevier on request. For more information, please review the Elsevier Policy on the Use of Images or
Personal Information of Patients or other Individuals. Unless you have written permission from the
patient (or, where applicable, the next of kin), the personal details of any patient included in any
part of the article and in any supplementary materials (including all illustrations and videos) must
be removed before submission.
Patients and Study Participants
Studies on patients or volunteers require ethics committee approval and informed consent which
should be documented in your paper.

Patients have a right to privacy. Therefore identifying information, including patient's photographs,
pedigree, images, names, initials, or hospital numbers, should not be included in the submissions
unless the information is essential for scientific purposes and written informed consent has been

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 7

obtained for publication in print and electronic form from the patient (or parent, guardian or next
of kin). If such consent is made subject to any conditions, Elsevier must be made aware of all such
conditions. Written consents must be provided to the journal on request.

Even where consent has been given, identifying details should be omitted if they are not essential.
Complete anonymity is difficult to achieve. For example, masking the eye region in photographs of
patients is inadequate protection of anonymity. If identifying characteristics are altered to protect
anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not
distort scientific meaning and editors should so note.
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Submit your article
Please submit your article via http://ees.elsevier.com/jdc.
Article types
N.B. For reasons of available space, manuscripts that exceed the required word limits (below) will
be declined automatically. All articles other than Editorials and Letters to the Editor are subject to
full peer review.
1. Editorials are either written or commissioned by the Editors and should not exceed 1000 words
(not including a maximum of 20 references; one small figure can be included).
2. Commentaries (1000 words not including a maximum of 20 references and one small figure)
offer a stimulating, journalistic and accessible insight into issues of common interest. They are
usually commissioned by the Editors but unsolicited articles will be considered. Debates comprise
two commentaries of opposing or contrasting opinion written by two different groups of authors.
Controversial opinions are welcomed as long as they are set in the context of the generally accepted
view.
3. Original Research Articles should be a maximum of 5000 words. The word limit includes a
combined total of five figures or tables with legends, but does not include up to 50 references
and an abstract of up to 200 words structured according to Aims, Methods, Results, Conclusions
and Keywords. Divide the manuscript into the following sections: Title Page; Structured Abstract;
Introduction; Subjects, Materials and Methods; Results; Discussion; Acknowledgements; References;
figures and tables with legends.
4. Brief Reports should not exceed 1000 words, including a summary of no more than 50 words
(but not including up to 20 references) and may be a preliminary report of work completed, a final
report or an observation not requiring a lengthy write-up.
5. Review articles should be a maximum of 5000 words, including a summary of no more than 200
words (not including up to 75 references) with subheadings in the text to highlight the content of
different sections. The world limit includes a combined total of five figures or tables with legends.
Reviews are generally commissioned by the Editors but unsolicited articles will be considered.
6. Letters to the Editor should be no more than 400 words.
Referees
Please submit the names and institutional e-mail addresses of several potential referees. For more
details, visit our Support site. Note that the editor retains the sole right to decide whether or not the
suggested reviewers are used.

PREPARATION
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting
codes will be removed and replaced on processing the article. In particular, do not use the word
processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts (see

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 8

also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics
will be required whether or not you embed your figures in the text. See also the section on Electronic
artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered
1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be
given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be
indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results
and Discussion section is often appropriate. Avoid extensive citations and discussion of published
literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand
alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
Author names and affiliations. Please clearly indicate the given name(s) and family name(s)
of each author and check that all names are accurately spelled. Present the authors' affiliation
addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-
case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name and, if available, the
e-mail address of each author.
Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing
and publication, also post-publication. Ensure that the e-mail address is given and that contact
details are kept up to date by the corresponding author.
Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as
a footnote to that author's name. The address at which the author actually did the work must be
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Structured abstract
A structured abstract, by means of appropriate headings, should provide the context or background for
the research and should state its purpose, basic procedures (selection of study subjects or laboratory
animals, observational and analytical methods), main findings (giving specific effect sizes and their
statistical significance, if possible), and principal conclusions. It should emphasize new and important
aspects of the study or observations.

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 9

Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing
with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords
will be used for indexing purposes.
Abbreviations
Define abbreviations at their first occurrence in the article: in the abstract and also in the main text
after it. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Formatting of funding sources
List funding sources in this standard way to facilitate compliance to funder's requirements:

Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy];
the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes
of Peace [grant number aaaa].

It is not necessary to include detailed descriptions on the program or type of grants and awards. When
funding is from a block grant or other resources available to a university, college, or other research
institution, submit the name of the institute or organization that provided the funding.

If no funding has been provided for the research, please include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or
not-for-profit sectors.
Units
Follow internationally accepted rules and conventions: use the international system of units (SI). If
other units are mentioned, please give their equivalent in SI.
Math formulae
Please submit math equations as editable text and not as images. Present simple formulae in
line with normal text where possible and use the solidus (/) instead of a horizontal line for small
fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often
more conveniently denoted by exp. Number consecutively any equations that have to be displayed
separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article. Many word
processors can build footnotes into the text, and this feature may be used. Otherwise, please indicate
the position of footnotes in the text and list the footnotes themselves separately at the end of the
article. Do not include footnotes in the Reference list.
Artwork
Electronic artwork
General points
Make sure you use uniform lettering and sizing of your original artwork.
Embed the used fonts if the application provides that option.
Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or
use fonts that look similar.
Number the illustrations according to their sequence in the text.
Use a logical naming convention for your artwork files.
Provide captions to illustrations separately.
Size the illustrations close to the desired dimensions of the published version.
Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 10

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is
finalized, please 'Save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of
500 dpi.
Please do not:
Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a
low number of pixels and limited set of colors;
Supply files that are too low in resolution;
Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF) or
MS Office files) and with the correct resolution. If, together with your accepted article, you submit
usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear
in color online (e.g., ScienceDirect and other sites) in addition to color reproduction in print. Further
information on the preparation of electronic artwork.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Please submit tables as editable text and not as images. Tables can be placed either next to the
relevant text in the article, or on separate page(s) at the end. Number tables consecutively in
accordance with their appearance in the text and place any table notes below the table body. Be
sparing in the use of tables and ensure that the data presented in them do not duplicate results
described elsewhere in the article. Please avoid using vertical rules and shading in table cells.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Reference links
Increased discoverability of research and high quality peer review are ensured by online links to
the sources cited. In order to allow us to create links to abstracting and indexing services, such as
Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please
note that incorrect surnames, journal/book titles, publication year and pagination may prevent link
creation. When copying references, please be careful as they may already contain errors. Use of the
DOI is encouraged.

A DOI can be used to cite and link to electronic articles where an article is in-press and full citation
details are not yet known, but the article is available online. A DOI is guaranteed never to change,
so you can use it as a permanent link to any electronic article. An example of a citation using DOI
for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M.
(2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal
of Geophysical Research, https://doi.org/10.1029/2001JB000884. Please note the format of such
citations should be in the same style as all other references in the paper.

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 11

Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
Data references
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them
in your text and including a data reference in your Reference List. Data references should include the
following elements: author name(s), dataset title, data repository, version (where available), year,
and global persistent identifier. Add [dataset] immediately before the reference so we can properly
identify it as a data reference. The [dataset] identifier will not appear in your published article.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
Reference management software
Most Elsevier journals have their reference template available in many of the most popular reference
management software products. These include all products that support Citation Style Language
styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-ins from
these products, authors only need to select the appropriate journal template when preparing their
article, after which citations and bibliographies will be automatically formatted in the journal's style.
If no template is yet available for this journal, please follow the format of the sample references and
citations as shown in this Guide.
Users of Mendeley Desktop can easily install the reference style for this journal by clicking the following
link:
http://open.mendeley.com/use-citation-style/journal-of-diabetes-and-its-complications
When preparing your manuscript, you will then be able to select this style using the Mendeley plug-
ins for Microsoft Word or LibreOffice.
Reference style
Text: Indicate references by (consecutive) superscript arabic numerals in the order in which they
appear in the text. The numerals are to be used outside periods and commas, inside colons and
semicolons. For further detail and examples you are referred to the AMA Manual of Style, A Guide for
Authors and Editors, Tenth Edition, ISBN 0-978-0-19-517633-9.
List: Number the references in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun.
2010;163:5159.
Reference to a book:
2. Strunk W Jr, White EB. The Elements of Style. 4th ed. New York, NY: Longman; 2000.
Reference to a chapter in an edited book:
3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith
RZ, eds. Introduction to the Electronic Age. New York, NY: E-Publishing Inc; 2009:281304.
Reference to a website:
4. Cancer Research UK. Cancer statistics reports for the UK. http://www.cancerresearchuk.org/
aboutcancer/statistics/cancerstatsreport/; 2003 Accessed 13.03.03.
Reference to a dataset:
[dataset] 5. Oguro, M, Imahiro, S, Saito, S, Nakashizuka, T. Mortality data for Japanese oak wilt
disease and surrounding forest compositions, Mendeley Data, v1; 2015. https://doi.org/10.17632/
xwj98nb39r.1.
Video
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include links to these within the body of the article. This can be done in the
same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly
relate to the video file's content. In order to ensure that your video or animation material is directly
usable, please provide the files in one of our recommended file formats with a preferred maximum size

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 12

of 150 MB. Video and animation files supplied will be published online in the electronic version of your
article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can
choose any frame from the video or animation or make a separate image. These will be used instead
of standard icons and will personalize the link to your video data. For more detailed instructions please
visit our video instruction pages. Note: since video and animation cannot be embedded in the print
version of the journal, please provide text for both the electronic and the print version for the portions
of the article that refer to this content.
Supplementary material
Supplementary material such as applications, images and sound clips, can be published with your
article to enhance it. Submitted supplementary items are published exactly as they are received (Excel
or PowerPoint files will appear as such online). Please submit your material together with the article
and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to
supplementary material during any stage of the process, please make sure to provide an updated file.
Do not annotate any corrections on a previous version. Please switch off the 'Track Changes' option
in Microsoft Office files as these will appear in the published version.
AudioSlides
The journal encourages authors to create an AudioSlides presentation with their published article.
AudioSlides are brief, webinar-style presentations that are shown next to the online article on
ScienceDirect. This gives authors the opportunity to summarize their research in their own words
and to help readers understand what the paper is about. More information and examples are
available. Authors of this journal will automatically receive an invitation e-mail to create an AudioSlides
presentation after acceptance of their paper.

AFTER ACCEPTANCE
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing
annotation and correction of proofs online. The environment is similar to MS Word: in addition to
editing text, you can also comment on figures/tables and answer questions from the Copy Editor.
Web-based proofing provides a faster and less error-prone process by allowing you to directly type
your corrections, eliminating the potential introduction of errors.

If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions
for proofing will be given in the e-mail we send to authors, including alternative methods to the online
version and PDF.

We will do everything possible to get your article published quickly and accurately - please upload
all of your corrections within 48 hours. It is important to ensure that all corrections are sent back
to us in one communication. Please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may
proceed with the publication of your article if no response is received.
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing
annotation and correction of proofs online. The environment is similar to MS Word: in addition to
editing text, you can also comment on figures/tables and answer questions from the Copy Editor.
Web-based proofing provides a faster and less error-prone process by allowing you to directly type
your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions
for proofing will be given in the e-mail we send to authors, including alternative methods to the online
version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this
proof only for checking the typesetting, editing, completeness and correctness of the text, tables and
figures. Significant changes to the article as accepted for publication will only be considered at this
stage with permission from the Editor. It is important to ensure that all corrections are sent back
to us in one communication. Please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility.

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 13

Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail (the PDF
file is a watermarked version of the published article and includes a cover sheet with the journal cover
image and a disclaimer outlining the terms and conditions of use). For an extra charge, paper offprints
can be ordered via the offprint order form which is sent once the article is accepted for publication.
Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop. Authors
requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book'
service to collate multiple articles within a single cover.

AUTHOR INQUIRIES
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from
Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will
be published.
Copyright 2014 Elsevier | http://www.elsevier.com

AUTHOR INFORMATION PACK 2 Apr 2017 www.elsevier.com/locate/jdiacomp 14